Dr Reddy’s Laboratories Ltd
The live share price of Dr Reddy's Laboratories Ltd (DRREDDY) as on 01 Jun 10:11am is ₹4,552.05 from NSE/BSE.
DRREDDY NSE
₹4,552.05 ▲1.13% (51)
As on Jun 01, 2023 03:41 PM IST
Key Metrics
PE Ratio
16.8
PB Ratio
3.94
Dividend Yield
0.88%
Sector PB
4.49
Sector PE
33.46
Sector Div Yld
0.82%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Largecap, ₹75,705 Cr
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
The following charts display the financial performance of the Dr Reddy's Laboratories Ltd (DRREDDY) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Dr Reddy's Laboratories Ltd (DRREDDY), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Sector
Health Care
Industry
Pharmaceuticals
Market Cap
Largecap, ₹75,705 Cr
Financials
Income Statement
| (INR) | Y/Y Change | |
| Revenue | 25,762 Cr | +16.57% |
| Operating Expense | 18,320 Cr | +571.33% |
| Net Income | 4,507 Cr | +106.52% |
| Net Profit Margin | 17.5% | +77.13% |
| Earning Per Share | 271 | +106.93% |
| EBITDA | 7,441 Cr | +72.16% |
Balance sheet
| (INR) | Y/Y Change | |
| Cash & short-term Inv | 4,436 Cr | +28.32% |
| Total Assets | 29,745 Cr | +11.88% |
| Total Liabilities | 10,533 Cr | +17.74% |
| Total Equity | 19,212 Cr | +8.9% |
| Shares Outstanding | 16.64 Cr | +0.06% |
| Price to Book | 3.71 | -14.21% |
| Return on Assets | 7.75% | -1.15% |
| Return on Capital | 16.43 Cr | -2.72% |
Cash Flows
| (INR) | Y/Y Change | |
| Net Income | 4,507 Cr | +106.52% |
| Cash from Operations | 2,810 Cr | -21.27% |
| Cash from Investing | -2,565 Cr | +13.78% |
| Cash from Financing | -242 Cr | +712.75% |
| Net Change in Cash | 3 Cr | -99.75% |
| Free Cash Flow | 905 Cr | -60.85% |
Peers
SUNPHARMA
Sun Pharmaceutical Industries Ltd
PE Ratio
27.27
1Y Return
▲13.33%
CIPLA
Cipla Ltd
PE Ratio
27.52
1Y Return
▼-4.02%
TORNTPHARM
Torrent Pharmaceuticals Ltd
PE Ratio
46.38
1Y Return
▲29.62%
MANKIND
Mankind Pharma Ltd
PE Ratio
0
1Y Return
▼-4.38%
Latest News
Neutral Dr Reddy’s Labs; target of Rs 4500: Motilal Oswal
3 weeks ago on Moneycontrol
Change since news ▼-0.44%
Motilal Oswal recommended Neutral rating on Dr Reddy’s Labs with a target price of Rs 4500 in its research report dated May 11, 2023.
Big Movers on D-St: What should investors do with Ratnamani Metal, Dr Reddy’s Laboratories and FSL?
3 weeks ago on Economic Times
Change since news ▼-0.44%
The S&P BSE Sensex and Nifty50 in India closed flat with a negative bias. Stocks in capital goods, healthcare, metals, and energy sectors experienced selling pressure, while consumer durables, FMCG, power, and utilities saw some buying. Ratnamani Metals rose over 6%, Dr Reddy’s Laboratories fell nea…
Dr Reddy’s Laboratories QoQ showing catches a cold on weak US sales
3 weeks ago on Business Standard
Change since news ▼-1.92%
While pharma major has maintained its margin guidance, expensive valuations limit upside
FAQs on Dr Reddy's Laboratories Ltd
How to buy Dr Reddy's Laboratories Ltd stocks?
You can easily buy the stocks/shares of Dr Reddy's Laboratories Ltd (DRREDDY) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Dr Reddy's Laboratories Ltd?
The stock price of Dr Reddy's Laboratories Ltd as on 01 Jun 2023 is ₹4,552.05
What is the 52-week High and Low of Dr Reddy's Laboratories Ltd?
The 52-week high and low of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹4,989 and ₹3,997.
What is the PE and PB ratio of Dr Reddy's Laboratories Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Dr Reddy's Laboratories Ltd are 16.8 and 3.94 respectively.
What are the peers or stocks similar to Dr Reddy's Laboratories Ltd?
The peers or stocks similar to Dr Reddy's Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Dr Reddy's Laboratories Ltd belong to?
Dr Reddy's Laboratories Ltd (DRREDDY) belongs to the Pharmaceuticals sector.
What is the Market Cap of Dr Reddy's Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Reddy's Laboratories Ltd (DRREDDY) is ₹75,705 Cr as of 01 Jun 2023
Can't decide whether or not to buy Dr Reddy's Laboratories Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.
smallcase Technologies Private Limited
#51, 3rd Floor, Le Parc Richmonde,
Richmond Road, Shanthala Nagar,
Richmond Town, Bangalore - 560025